Ohio State hematologist Dr. Kerry Rogers says chemotherapy and newer targeted drugs both work well, and the right choice depends on the patient.
Press Release|Articles|May 1, 2025
Triage Health Conference: Free Education to Navigate Health Care
Author(s)Triage Cancer®
Listen
0:00 / 0:00
Key Takeaways
- Triage Health Conference provides expert-led education on legal and practical issues for chronic or serious medical conditions.
- The event covers health insurance, finances, employment rights, and advocacy, targeting patients, caregivers, and healthcare professionals.
Triage Health offers free, expert-led education on the legal and practical issues that impact individuals coping with chronic or serious medical conditions.
Advertisement
Triage Health offers free, expert-led education on the legal and practical issues that impact individuals coping with chronic or serious medical conditions. Through our Triage Health Conference, we provide guidance on key topics including health and disability insurance, finances, employment rights, advocacy, and more. This event is part of the broader work of Triage Cancer.
About the Conference
Our next Triage Health Conference will take place online on May 17.
Who Should Attend?
This conference is designed for:
- Individuals diagnosed with chronic or serious medical conditions (e.g., cancer)
- Caregivers and family members
- Health care professionals
- Advocates and anyone interested in health care rights and resourcesContinuing education (CE) credits or professional development credits are available for nurses, social workers, patient advocates, and human resource professionals.Why Attend?
Learn how to reduce the financial and emotional burden of a medical diagnosis. We’ll giveyou the tools to make confident decisions about insurance, work, and other real-life challenges. Topics include: - Understanding your health insurance options
- Appealing denials and picking the right plan
- Managing medical bills and finding financial assistance
- Navigating employment decisions
- Organizing legal and financial documents
- Estate planning and advance directives
- Becoming an empowered patient and advocateRegister TodayDon’t miss this opportunity to gain valuable, actionable information—and have some fun, too! Join us for a day of education, connection, games, and prizes. triagecancer.org/conferences/may-2025
Advertisement
Related to this article
Given an 18-month prognosis for peritoneal mesothelioma in 2007, a mother shares the joy of tapping her son out at his Air Force basic training graduation.
A once-daily oral pill gives patients with symptomatic TGCT another option when surgery could cause more harm than good.
For World NET Cancer Day, CURE answers seven common questions about neuroendocrine tumors, from carcinoid syndrome and Ki-67 to dotatate PET scans and treatment options.
Up to 40% of patients with classic hairy cell leukemia relapse within 10 to 15 years. An NIH researcher explains how adding Rituxan up front may help.
Gita Kwatra, PharmD, MBA, co-founder and CEO of the Glioblastoma Foundation, explains what happens to tumor tissue after brain surgery and how patients can ask their care team for genomic testing.
Most people with pancreatic cancer lose weight they didn't mean to. Here is how weight loss from poor digestion differs from cachexia, and what enzymes, eating strategies and appetite medicines can do.
Dr. Rebecca Dent explains how Datroway kept brain metastases in check longer than chemotherapy in triple-negative breast cancer, and what patients should know.
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Pimicotinib for Tenosynovial Giant Cell Tumor
2
Neuroendocrine Tumors: 7 Questions Patients Ask, Answered
3
Why Rituxan Plus Cladribine May Delay Hairy Cell Leukemia Relapse
4
Datroway Slows Brain Metastases in Triple-Negative Breast Cancer
5